Serbia, Republic of vs Zimbabwe: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Serbia, Republic of
91.0%
in 2025
Zimbabwe
91.0%
in 2025
Serbia, Republic of rank
59th
Zimbabwe rank
59th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Serbia, Republic of
- Zimbabwe
How they compare
Serbia, Republic of currently reports 91.0% against 91.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Zimbabwe ahead.
Serbia, Republic of ranks 59th and Zimbabwe ranks 59th of 192 countries.
Zimbabwe has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Serbia, Republic of | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 15.9% | 65.2% | 49.3% | Zimbabwe |
| 2020s | 87.5% | 89.3% | 1.8% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Serbia, Republic of or Zimbabwe?
- Serbia, Republic of, at 91.0% against 91.0% in Zimbabwe as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Serbia, Republic of and Zimbabwe?
- 0.0%, with Serbia, Republic of ahead.
- How many years of comparable data are there for Serbia, Republic of and Zimbabwe?
- 18 years are reported by both, from 2008 to 2025.
- How do Serbia, Republic of and Zimbabwe rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Serbia, Republic of ranks 59th and Zimbabwe ranks 59th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.